Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ - Raymond James upgrades T-Mobile rating to "Outperform", shares rise

BUZZ - Raymond James upgrades T-Mobile rating to "Outperform", shares rise

路透社路透社2026/10/12 14:36
Show original

- ** Telecom operator T-Mobile (TMUS.O) shares rose about 3% in early trading, at $152.40

** Raymond James upgraded its rating from “Market Perform” to “Outperform”; target price set at $170

** The firm believes that recent market concerns over competition from SpaceX SPCX.O appear to be exaggerated

** It added that the recent pullback in the share price has made the stock’s valuation more attractive relative to its growth prospects and to peers such as AT&T and Verizon

** Out of 18 brokerages, 14 rate the stock as “Buy” or higher, while 4 give it a “Hold” rating; the median target price is $235 — data compiled by LSEG

** As of the previous trading day's close, the stock had declined about 27% year-to-date


(To assist non-English speakers, Reuters has automatically translated its reporting into several other languages. Because automated translation may contain errors or may not provide the needed context, Reuters does not guarantee the accuracy of the translated text. The automated translation is provided solely for readers' convenience. Reuters accepts no liability for any damage or loss caused by the use of the automated translation function.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56

Kroger (KR.US) faces the largest layoffs in 143 years: cutting one-third of positions, more than 3,000 employees to be let go

Kroger has laid off 3,000 employees, accounting for more than one-third of its total workforce, marking the largest layoff in its 143-year history. The resources saved will be redirected towards price reductions and frontline operations.

智通财经•2026/10/13 01:36